Xiaolin Zhu

机构：University of California, San Francisco, Inner Mongolia University, Shanghai Technical Institute of Electronics & Information, UCSF Helen Diller Family Comprehensive Cancer Center, China Agricultural University, Inner Mongolia University of Technology · ORCID：0000-0002-3221-595X

发表论文 373 篇 · 总被引 6118 次 · h-index 39

代表论文

Pericyte-myofibroblast transition: a novel mechanism in peritoneal fibrosis and the effect of Asiaticoside (2025 · Journal of Advanced Research · 被引 3)
Supplementary Figure 3 from Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer (2026)
Supplementary Table S3 from Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies (2026)
Supplementary Figure 1 from Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer (2026)
Data from Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies (2026)
Supplementary Table S1 from Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies (2026)